Here's What Key Metrics Tell Us About Dolby Laboratories (DLB) Q2 Earnings

Dolby Laboratories (DLB) reported $369.56 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.4%. EPS of $1.34 for the same period compares to $1.27 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $378.68 million, representing a surprise of -2.41%. The company delivered an EPS surprise of +3.88%, with the consensus EPS estimate being $1.29.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Dolby Laboratories performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Products and services: $23.56 million compared to the $28.20 million average estimate based on three analysts. The reported number represents a change of -10.4% year over year. Revenue- Licensing: $346.01 million versus $350.48 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +2.3% change. Gross Margin- Licensing: $326.32 million versus $331.80 million estimated by three analysts on average. Gross margin- Products and services: $7.40 million compared to the $6.77 million average estimate based on three analysts. View all Key Company Metrics for Dolby Laboratories here>>>Shares of Dolby Laboratories have returned -5.4% over the past month versus the Zacks S&P 500 composite's -0.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dolby Laboratories (DLB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks